Acetylenic mechanism-based inhibitors of cholesterol side chain cleavage by cytochrome P-450scc. 1983

A Nagahisa, and R W Spencer, and W H Orme-Johnson

The following acetylenic steroids appear to be the first reported mechanism-based inhibitors of cytochrome P-450scc: 20-(1-propynyl)-5-pregnen-3 beta, 20 alpha-diol, 20-(1-hexynyl)-5-pregnen-3 beta, 20 alpha-diol, and 20-(1,5-hexadiynyl)5-pregnen-3 beta, 20 alpha-diol. Oxygen and NADPH are required for enzymatic oxidation and all three steroids yield pregnenolone as a major product. Incubation of P-450scc with 20-(1,5-hexadiynyl)-5-pregnen-3 beta, 20 alpha-diol under turnover conditions completely inactivates the enzyme with a half-time of 11 min. The partition ratio for inactivation by the steroid was determined to be about 6 molecules of the steroid processed per molecule of P-450scc inactivated.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008861 Microsomes Artifactual vesicles formed from the endoplasmic reticulum when cells are disrupted. They are isolated by differential centrifugation and are composed of three structural features: rough vesicles, smooth vesicles, and ribosomes. Numerous enzyme activities are associated with the microsomal fraction. (Glick, Glossary of Biochemistry and Molecular Biology, 1990; from Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) Microsome
D011284 Pregnenolone A 21-carbon steroid, derived from CHOLESTEROL and found in steroid hormone-producing tissues. Pregnenolone is the precursor to GONADAL STEROID HORMONES and the adrenal CORTICOSTEROIDS. 5-Pregnen-3-beta-ol-20-one,5 Pregnen 3 beta ol 20 one
D005287 Ferredoxin-NADP Reductase An enzyme that catalyzes the oxidation and reduction of FERREDOXIN or ADRENODOXIN in the presence of NADP. EC 1.18.1.2 was formerly listed as EC 1.6.7.1 and EC 1.6.99.4. Adrenodoxin Reductase,Iron-Sulfur Protein Reductase,NADPH-Ferredoxin Reductase,Ferredoxin NADP Reductase,Iron Sulfur Protein Reductase,NADPH Ferredoxin Reductase,Protein Reductase, Iron-Sulfur,Reductase, Adrenodoxin,Reductase, Ferredoxin-NADP,Reductase, Iron-Sulfur Protein,Reductase, NADPH-Ferredoxin
D000325 Adrenodoxin An iron-sulfur protein which serves as an electron carrier in enzymatic steroid hydroxylation reactions in adrenal cortex mitochondria. The electron transport system which catalyzes this reaction consists of adrenodoxin reductase, NADP, adrenodoxin, and cytochrome P-450.
D000480 Alkynes Hydrocarbons with at least one triple bond in the linear portion, of the general formula Cn-H2n-2. Acetylenic Compounds,Alkyne,Acetylenes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D065607 Cytochrome P-450 Enzyme Inhibitors Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 ENZYMES. Cytochrome P-450 Inhibitors,Cytochrome P-450 Monooxygenase Inhibitors,Cytochrome P-450 Oxygenase Inhibitors,Cytochrome P-450-Dependent Monooxygenase Inhibitors,P-450 Enzyme Inhibitors,P450 Enzyme Inhibitors,Cytochrome P 450 Dependent Monooxygenase Inhibitors,Cytochrome P 450 Enzyme Inhibitors,Cytochrome P 450 Inhibitors,Cytochrome P 450 Monooxygenase Inhibitors,Cytochrome P 450 Oxygenase Inhibitors,Enzyme Inhibitors, P-450,Enzyme Inhibitors, P450,Inhibitors, Cytochrome P-450,Inhibitors, P-450 Enzyme,Inhibitors, P450 Enzyme,P 450 Enzyme Inhibitors,P-450 Inhibitors, Cytochrome

Related Publications

A Nagahisa, and R W Spencer, and W H Orme-Johnson
July 1983, The Journal of biological chemistry,
A Nagahisa, and R W Spencer, and W H Orme-Johnson
July 1990, Journal of steroid biochemistry,
A Nagahisa, and R W Spencer, and W H Orme-Johnson
September 1978, Archives of biochemistry and biophysics,
A Nagahisa, and R W Spencer, and W H Orme-Johnson
December 1990, The Journal of biological chemistry,
A Nagahisa, and R W Spencer, and W H Orme-Johnson
May 1983, Molecular pharmacology,
A Nagahisa, and R W Spencer, and W H Orme-Johnson
September 1987, Molecular and cellular endocrinology,
A Nagahisa, and R W Spencer, and W H Orme-Johnson
March 1997, European journal of biochemistry,
A Nagahisa, and R W Spencer, and W H Orme-Johnson
December 1979, The Journal of biological chemistry,
A Nagahisa, and R W Spencer, and W H Orme-Johnson
March 1979, Biochemical and biophysical research communications,
A Nagahisa, and R W Spencer, and W H Orme-Johnson
August 1996, The Journal of steroid biochemistry and molecular biology,
Copied contents to your clipboard!